Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Aug 11, 2026

Pediatrix Medical Group, Inc. (MD)

A forensic read on Pediatrix Medical Group, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective

Forensic grade

Safe

Financial health

3.0

Distress distance

Clean

Earnings quality

Forensic signals

12.6

P / E (ttm)

19.1%

ROE

$2.1B

Market cap

-4.9%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Pediatrix Medical Group, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 3.0, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

11.1%

FY2025

Return on invested capital. Return on invested capital is 11.1% in the latest fiscal year and rising from 7% — a modest positive spread over its ~10% cost of capital — growth adds value, though not dramatically.

+0.5%/yr

FY2022–FY2025

Share count. Diluted share count changed +1% over the last 3 years to FY2025 (+0.5%/yr). Roughly flat — buybacks ($87M) are about offsetting stock comp ($18M), not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.

$1.7B

FY2019–FY2024

Goodwill impairments. Took $1.7B of goodwill writedowns across 3 years (FY2019 ($1.4B), FY2023 ($148M), FY2024 ($151M)). Writedowns mean past acquisitions underperformed what was paid for them.

Key fundamentals

Latest Revenue$1.91B

Revenue Growth YoY-4.9%

Revenue CAGR (3yr)-1.0%

Net Margin8.6%

Free Cash Flow$252.6M

Return on Equity19.1%

Debt / Equity0.69x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Pediatrix Medical Group, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 11, 2026. Forensic signals flag probability, not certainty.